| Product Code: ETC7539303 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India cardiovascular drugs market import shipment experienced a slight decline with a negative CAGR from 2020 to 2024. However, there was a notable upturn in growth between 2023 and 2024, indicating a potential rebound. Overall, the market showed signs of stabilization amidst fluctuations.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cardiovascular Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cardiovascular Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Cardiovascular Drugs Market - Industry Life Cycle |
3.4 India Cardiovascular Drugs Market - Porter's Five Forces |
3.5 India Cardiovascular Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Cardiovascular Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 India Cardiovascular Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Cardiovascular Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in India |
4.2.2 Growing adoption of unhealthy lifestyles leading to higher cardiovascular risks |
4.2.3 Rising awareness about cardiovascular health and the importance of early diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 High cost associated with cardiovascular drugs and treatments |
4.3.3 Limited access to quality healthcare services in rural areas |
5 India Cardiovascular Drugs Market Trends |
6 India Cardiovascular Drugs Market, By Types |
6.1 India Cardiovascular Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Cardiovascular Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Cardiovascular Drugs Market Revenues & Volume, By Renin-Angiotensin System Blockers (ACE Inhibitors and Angiotensin Receptor Blockers), 2021- 2031F |
6.1.4 India Cardiovascular Drugs Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.1.5 India Cardiovascular Drugs Market Revenues & Volume, By Diuretics, 2021- 2031F |
6.1.6 India Cardiovascular Drugs Market Revenues & Volume, By Anti-Clotting Agents (Anti-Coagulants and Platelet Aggregation Inhibitors), 2021- 2031F |
6.1.7 India Cardiovascular Drugs Market Revenues & Volume, By Antihyperlipidemics, 2021- 2031F |
6.1.8 India Cardiovascular Drugs Market Revenues & Volume, By Other Antihypertensive, 2021- 2031F |
6.1.9 India Cardiovascular Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 India Cardiovascular Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Cardiovascular Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Cardiovascular Drugs Market Revenues & Volume, By Hypertension, 2021- 2031F |
6.2.3 India Cardiovascular Drugs Market Revenues & Volume, By Hyperlipidemia, 2021- 2031F |
6.2.4 India Cardiovascular Drugs Market Revenues & Volume, By Coronary Artery Disease, 2021- 2031F |
6.2.5 India Cardiovascular Drugs Market Revenues & Volume, By Peripheral Artery Disease, 2021- 2031F |
6.2.6 India Cardiovascular Drugs Market Revenues & Volume, By Arrhythmia, 2021- 2031F |
6.2.7 India Cardiovascular Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Cardiovascular Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Cardiovascular Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 India Cardiovascular Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 India Cardiovascular Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 India Cardiovascular Drugs Market Import-Export Trade Statistics |
7.1 India Cardiovascular Drugs Market Export to Major Countries |
7.2 India Cardiovascular Drugs Market Imports from Major Countries |
8 India Cardiovascular Drugs Market Key Performance Indicators |
8.1 Number of patients diagnosed with cardiovascular diseases annually |
8.2 Percentage of the population using cardiovascular drugs as preventive medication |
8.3 Rate of adoption of new cardiovascular drug therapies |
8.4 Number of healthcare facilities offering cardiovascular treatments |
8.5 Average time taken for drug approval and market entry in India |
9 India Cardiovascular Drugs Market - Opportunity Assessment |
9.1 India Cardiovascular Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Cardiovascular Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 India Cardiovascular Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Cardiovascular Drugs Market - Competitive Landscape |
10.1 India Cardiovascular Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Cardiovascular Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here